SPONSOR
Institut National de la Santé Et de la Recherche Médicale, France
Total Trials
6
Recruiting
6
Phases
Phase 1
Conditions studied: Congenital Heart DiseaseCyanotic Congenital Heart Diseased-Transposition of the Great ArteriesHypoplastic Left Heart SyndromeProstate CancerTBI (Traumatic Brain Injury)Infectious DiseasePharmacologyChronic Liver Disease and CirrhosisLiver Cancer
Institut National de la Santé Et de la Recherche Médicale, France is a clinical research sponsor with 6 registered studies on ClinicalTrials.gov, of which 6 are actively recruiting participants. Research covers conditions including Congenital Heart Disease, Cyanotic Congenital Heart Disease, d-Transposition of the Great Arteries, Hypoplastic Left Heart Syndrome.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Institut National de la Santé Et de la Recherche Médicale, France
How many clinical trials has Institut National de la Santé Et de la Recherche Médicale, France sponsored?
ClinicalMetric currently tracks 6 clinical trials sponsored by Institut National de la Santé Et de la Recherche Médicale, France, of which 6 are actively recruiting participants. These trials cover conditions including Congenital Heart Disease, Cyanotic Congenital Heart Disease, d-Transposition of the Great Arteries. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Institut National de la Santé Et de la Recherche Médicale, France research focus on?
Institut National de la Santé Et de la Recherche Médicale, France clinical trials span Congenital Heart Disease, Cyanotic Congenital Heart Disease, d-Transposition of the Great Arteries, Hypoplastic Left Heart Syndrome, Prostate Cancer, and additional conditions. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Institut National de la Santé Et de la Recherche Médicale, France clinical trial?
To participate in a Institut National de la Santé Et de la Recherche Médicale, France trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Institut National de la Santé Et de la Recherche Médicale, France trials with current recruitment status updated daily.
Clinical Trials by Institut National de la Santé Et de la Recherche Médicale, France
NCT06711666
Recruiting
Prenatal Maternal Mental Health and Neurodevelopment in Congenital Heart Disease
Congenital Heart Disease
NCT06773806
Recruiting
CHLORDECONE EXPOSURE AND PROSTATE CANCER IN THE FRENCH REGION OF MARTINIIQUE
Prostate Cancer
NCT06024122
Recruiting
Brain Development in Young Children Following Mild Traumatic Brain Injury - Pilot Study
TBI (Traumatic Brain Injury)
NCT06024421 Phase 1
Recruiting
Evaluation of Tolerance and Pharmacokinetic Profile of High Doses of Favipiravir in Healthy Volunteers
Infectious Disease
NCT04690972
Recruiting
"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".
Chronic Liver Disease and Cirrhosis
NCT05277519
Recruiting
Neuroplasticity After Proprioceptive Rehabiliation
Stroke
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology